Valeant Pharmaceuticals has purchased Pedinol Pharmacal and the transaction is expected to be immediately accretive.
Pedinol Pharmacal is a podiatry-focused, privately-owned specialty pharmaceutical company based in the US.
Valeant chairman and chief executive officer Michael Pearson said that the Pedinol business will be a strong fit alongside Valeant's dermatology franchise.
"Pedinol has over 85 years of experience in podiatry and a highly regarded national field sales organization, which are both key as we prepare for broader expansion into this market," Pearson added.
Source:
http://inwardinvestment.pharmaceutical-business-review.com/news/valeant-takes-over-pedinol-pharmacal-130412
